Abstract:Background In addition to deconditioning, persistent low-grade inflammation following acute SARS-CoV-2 infection may contribute to systemic problems, which supports the need for further assessment of cardiopulmonary conditioning. In fact, the impairment of the respiratory system in the acute phase of COVID-19 has the potential to significantly impact functional capacity in patients with post-COVID-19 syndrome (PCS), with dynamic hyperinflation (DH) and reduced ventilatory reserve (RV). Objective To investigate the dynamic ventilatory responses and their influence on the functional capacity to exercise in these patients. Methods Between March and October 2022, a cross-sectional study was carried out with 16 patients with PCS aged ≥18 years attended at the Piquet Carneiro Polyclinica, at the State University of Rio de Janeiro. Patients with a history of COVID-19 pneumonia with persistence of respiratory symptoms after 3 months of the acute phase were included. Patients without a previous diagnosis of COVID-19 confirmed by RT-PCR (reverse-transcription polymerase chain reaction) and those who failed to perform the protocol tests were excluded. Patients underwent impulse oscillometry (IOS), spirometry, 6-minute walk test (6MWT) with Spiropalm®-6MWT, and cardiopulmonary exercise test (CPET). A ≥100 ml decrease in inspiratory capacity (IC) during exercise was defined as HD. Ventilatory reserve (VR) indicates how close minute ventilation (VE) approaches maximum voluntary ventilation (MVV) during a given activity and was calculated as the difference between MVV and VEpeak ([MVV-VEpeak]/MVV); VR <30% was considered to be ventilatory limitation on exertion. Results Median age and time since diagnosis of COVID-19 were 57 (50–59) years and 98 (93–106) days, respectively. Regarding spirometry, 12.5% and 50% of the participants had an abnormal spirometry and an altered IOS, respectively, and the difference in resistance between 4 Hz and 20 Hz (R4-R20) was detected in 31.2% of the participants. cases. Regarding cardiopulmonary performance during exercise, the median distance in the 6MWT was 83 (78–97) % of predicted, with HD and VR <30% observed in 62.5% and 12.5% of participants, respectively. In CPET, the median peak oxygen consumption (VO2peak) was 19 (14–37) ml/kg/min. There was a significant correlation of the distance covered in the 6MWT with both R4-R20 (rs = -0.499, P = 0.039) and VO2peak (rs = 0.628, P = 0.009). Conclusion Our findings suggest that HD and, to a lesser extent, low VR are contributors to poor exercise performance that is associated with peripheral airway disease. Implications Based on these results, we obtained precise ventilatory and metabolic measurements, which we can consider as an important factor for more assertive exercise prescription during the rehabilitation of these patients. Moreover, these results are promising if we consider that they were obtained with simple, cheap, and portable ventilatory and metabolic measurement systems, easily applicable in real-world environments.

Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection: A Cross-Sectional Study Israel

Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infection

Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study

Effect of covid-19 vaccination on long covid: systematic review

Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis

Does COVID-19 impair V̇o2peak in patients with cardiorespiratory disease? Insight from cardiopulmonary responses to maximal exercise pre- and post-illness

Real-world Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents

Long COVID after breakthrough SARS-CoV-2 infection

Long-term COVID-19 effects on pulmonary function, exercise capacity, and health status

Reduction in Long COVID Symptoms and Symptom Severity in Vaccinated Compared to Unvaccinated Adults

Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults

Mild-to-moderate COVID-19 impact on the cardiorespiratory fitness in young and middle-aged populations

Long-term effect of non-severe COVID-19 on pulmonary function, exercise capacities and physical activities: a cross-section study in Sakaka Aljouf

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study

Determinants of cardiorespiratory fitness measured by cardiopulmonary exercise testing in COVID-19 survivors: a systematic review with meta-analysis and meta‑regression

Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life

A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID

EVALUATION OF VENTILATION DURING EXERCISE TESTS IN PEOPLE WITH POST-COVID-19 SYNDROME

Cardiopulmonary exercise test 3 to 12 months after COVID-19 hospitalization